Significance and expression of p-Akt in oral squamous cell carcinoma
- PMID: 37082060
- PMCID: PMC10112077
- DOI: 10.4103/jomfp.JOMFP_256_20
Significance and expression of p-Akt in oral squamous cell carcinoma
Abstract
Background: Oral cancer is considered as the sixth-most common malignant neoplasm in the world and the most common type is squamous cell carcinoma (SCC). Akt is a serine/threonine-protein kinase, that acts in the regulation of different signaling downstream pathways, including; proliferation, growth, cell metabolism, angiogenesis and survival. The objective of the present study was to show the expression of p-Akt and its prognostic effect in oral SCC (OSCC).
Materials and methods: A total of 72 cases of OSCC were included in this study; the expression of the Akt gene was done on 4 μm tumor sections using immunohistochemical staining of Akt antibody.
Results: Histopathological examination showed that: (43) were GIII, (13) cases were GII, and (16) cases were GI. The positivity of immunohistochemical staining were appear as brown stain. Results showed increase expression of p-Akt in most cases of oral SCC and mean expression about (54.86 ± 31.58), and the expression of p-Akt was increased with the progression of the histological grade of the tumor.
Conclusion: High expression of p-Akt and its relation with the progression of tumor grade and invasion of tumor may indicate the relationship between p-Akt expression and aggressiveness and progression of the tumor.
Keywords: Immunohistochemistry; Oral cancer; Oral squamous cell carcinoma; Phosphorylated Akt.
Copyright: © 2022 Journal of Oral and Maxillofacial Pathology.
Conflict of interest statement
There are no conflicts of interest.
Figures






Similar articles
-
Characterization of DJ-1, PTEN, and p-Akt as Prognostic Biomarkers in the Progression of Oral Squamous Cell Carcinoma.Cureus. 2023 Jan 31;15(1):e34436. doi: 10.7759/cureus.34436. eCollection 2023 Jan. Cureus. 2023. PMID: 36874678 Free PMC article.
-
The role of p21-activated kinase 4 in the progression of oral squamous cell carcinoma by targeting PI3K-AKT signaling pathway.Clin Transl Oncol. 2023 Mar;25(3):739-747. doi: 10.1007/s12094-022-02980-y. Epub 2023 Jan 2. Clin Transl Oncol. 2023. PMID: 36593383
-
Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.Arch Oral Biol. 2018 Dec;96:74-79. doi: 10.1016/j.archoralbio.2018.08.018. Epub 2018 Aug 30. Arch Oral Biol. 2018. PMID: 30195142
-
Immunohistochemical study of CD44s expression in oral squamous cell carcinoma-its correlation with prognostic parameters.J Oral Maxillofac Pathol. 2014 May;18(2):162-8. doi: 10.4103/0973-029X.140722. J Oral Maxillofac Pathol. 2014. PMID: 25328293 Free PMC article.
-
Two different protein expression profiles of oral squamous cell carcinoma analyzed by immunoprecipitation high-performance liquid chromatography.World J Surg Oncol. 2017 Aug 8;15(1):151. doi: 10.1186/s12957-017-1213-5. World J Surg Oncol. 2017. PMID: 28789700 Free PMC article. Review.
Cited by
-
Longikaurin A, a natural ent-kaurane, suppresses proliferation, invasion and tumorigenicity in oral squamous cell carcinoma cell by via inhibiting PI3K/Akt pathway in vitro and in vivo.J Cancer. 2025 Jan 1;16(3):708-719. doi: 10.7150/jca.102125. eCollection 2025. J Cancer. 2025. PMID: 39781358 Free PMC article.
-
The HIV Protease Inhibitor Ritonavir Reverts the Mesenchymal Phenotype Induced by Inflammatory Cytokines in Normal and Tumor Oral Keratinocytes to an Epithelial One, Increasing the Radiosensitivity of Tumor Oral Keratinocytes.Cancers (Basel). 2025 Jul 30;17(15):2519. doi: 10.3390/cancers17152519. Cancers (Basel). 2025. PMID: 40805215 Free PMC article.
-
Dysregulated PI3K/AKT signaling in oral squamous cell carcinoma: The tumor microenvironment and epigenetic modifiers as key drivers.Oncol Res. 2025 Jul 18;33(8):1835-1860. doi: 10.32604/or.2025.064010. eCollection 2025. Oncol Res. 2025. PMID: 40746882 Free PMC article. Review.
References
-
- Malone JP, Stephens JA, Grecula JC, Rhoades CA, Ghaheri BA, Schuller DE. Disease control, survival and functional outcome after multimodal treatment for advanced – Stage tongue base cancer. J Head Neck. 2004;26:561–72. - PubMed
-
- Plame CE, Gullane PJ, Gilbert RW. Current treatment options in squamous cell carcinoma of the oral cavity. J Surg Oncol Clin N Am. 2004;13:47–70. - PubMed
-
- Nicholson KM, Anderson AG. The protein kinase B/Akt signaling pathway in human malignancy. J Cell Signal. 2002;14:381–95. - PubMed
-
- Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the P13K/AKT pathway for cancer drug discovery. J Nat Rev Drug Discov. 2005;4:988–1004. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials